NCT07000253 2025-06-02
OMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2/3 Not yet recruiting
Clinical Trials
13 trialsNCT05504265 2025-03-20
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Recruiting
NCT06782412 2025-02-07
FAPIDO
KU Leuven
Phase 2/3 Recruiting
NCT01404156 2024-08-28
POWERRANGER
CancerCare Manitoba
Phase 2/3 Completed
NCT01348217 2020-01-27
CONCORDE
Centre Georges Francois Leclerc
Phase 2/3 Completed
NCT01446874 2018-11-08
POPP
Washington University School of Medicine
Phase 2/3 Terminated
NCT03285906 2017-09-18
An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT00160875 2017-05-04
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer
University Health Network, Toronto
Phase 2/3 Completed
NCT01704690 2017-04-07
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Peking University
Phase 2/3 Terminated
NCT01242124 2015-12-22
Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT00861094 2015-12-18
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
UNICANCER
Phase 2/3 Completed
NCT00002930 2013-01-18
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2/3 Completed
NCT00509561 2012-12-18
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Wales Cancer Trials Unit
Phase 2/3 Unknown